178 related articles for article (PubMed ID: 15537822)
1. Protease inhibitor treatments reveal specific involvement of matrix metalloproteinase-9 in human adipocyte differentiation.
Bourlier V; Zakaroff-Girard A; De Barros S; Pizzacalla C; de Saint Front VD; Lafontan M; Bouloumié A; Galitzky J
J Pharmacol Exp Ther; 2005 Mar; 312(3):1272-9. PubMed ID: 15537822
[TBL] [Abstract][Full Text] [Related]
2. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes.
Croissandeau G; Chrétien M; Mbikay M
Biochem J; 2002 Jun; 364(Pt 3):739-46. PubMed ID: 12049638
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9.
De Barros S; Zakaroff-Girard A; Lafontan M; Galitzky J; Bourlier V
J Pharmacol Exp Ther; 2007 Jan; 320(1):291-9. PubMed ID: 17038510
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation.
Bouloumié A; Sengenès C; Portolan G; Galitzky J; Lafontan M
Diabetes; 2001 Sep; 50(9):2080-6. PubMed ID: 11522674
[TBL] [Abstract][Full Text] [Related]
6. Effect of tissue inhibitor of matrix metalloproteinases-1 on in vitro and in vivo adipocyte differentiation.
Scroyen I; Cosemans L; Lijnen HR
Thromb Res; 2009 Nov; 124(5):578-83. PubMed ID: 19608218
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
Chavey C; Mari B; Monthouel MN; Bonnafous S; Anglard P; Van Obberghen E; Tartare-Deckert S
J Biol Chem; 2003 Apr; 278(14):11888-96. PubMed ID: 12529376
[TBL] [Abstract][Full Text] [Related]
8. Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes.
Janneh O; Hoggard PG; Tjia JF; Jones SP; Khoo SH; Maher B; Back DJ; Pirmohamed M
Antivir Ther; 2003 Oct; 8(5):417-26. PubMed ID: 14640389
[TBL] [Abstract][Full Text] [Related]
9. The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes.
Grigem S; Fischer-Posovszky P; Debatin KM; Loizon E; Vidal H; Wabitsch M
Horm Metab Res; 2005 Oct; 37(10):602-9. PubMed ID: 16278782
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases of human NK cells.
Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
Lagathu C; Bastard JP; Auclair M; Maachi M; Kornprobst M; Capeau J; Caron M
Antivir Ther; 2004 Dec; 9(6):911-20. PubMed ID: 15651750
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
[TBL] [Abstract][Full Text] [Related]
13. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Jones SP; Janneh O; Back DJ; Pirmohamed M
Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
[TBL] [Abstract][Full Text] [Related]
14. Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development.
Lee PP; Hwang JJ; Mead L; Ip MM
J Cell Physiol; 2001 Jul; 188(1):75-88. PubMed ID: 11382924
[TBL] [Abstract][Full Text] [Related]
15. HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism.
Kim RJ; Wilson CG; Wabitsch M; Lazar MA; Steppan CM
Obesity (Silver Spring); 2006 Jun; 14(6):994-1002. PubMed ID: 16861604
[TBL] [Abstract][Full Text] [Related]
16. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
Lagathu C; Eustace B; Prot M; Frantz D; Gu Y; Bastard JP; Maachi M; Azoulay S; Briggs M; Caron M; Capeau J
Antivir Ther; 2007; 12(4):489-500. PubMed ID: 17668557
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells.
Duszyk M; Shu Y; Sawicki G; Radomski A; Man SF; Radomski MW
Can J Physiol Pharmacol; 1999 Jul; 77(7):529-35. PubMed ID: 10535713
[TBL] [Abstract][Full Text] [Related]
18. In combination, nucleoside reverse transcriptase inhibitors have significant effects on 3T3-L1 adipocyte lipid accumulation and survival.
Kosmiski LA; Miller HL; Klemm DJ
Antivir Ther; 2006; 11(2):187-95. PubMed ID: 16640100
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
Zervos EE; Shafii AE; Haq M; Rosemurgy AS
J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
[TBL] [Abstract][Full Text] [Related]
20. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
